Related references
Note: Only part of the references are listed.Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer
Joel Shapiro et al.
ANNALS OF SURGERY (2017)
MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy
Jing Wen et al.
ANNALS OF SURGERY (2016)
Postoperative Adjuvant Therapy Improves Survival in Pathologic Nonresponders After Neoadjuvant Chemoradiation for Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis
Heng-Yuan Hsu et al.
ANNALS OF THORACIC SURGERY (2016)
Prognosis of Patients With Pathologic T0 N+ Esophageal Squamous Cell Carcinoma After Chemoradiotherapy and Surgical Resection: Results From a Nationwide Study
Yin-Kai Chao et al.
ANNALS OF THORACIC SURGERY (2016)
Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma
Yoichi Hamai et al.
ANNALS OF THORACIC SURGERY (2016)
Adjuvant Therapy for Positive Nodes After Induction Therapy and Resection of Esophageal Cancer
Alexander A. Brescia et al.
ANNALS OF THORACIC SURGERY (2016)
Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma
Raed M. Alnaji et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer
Yoichi Hamai et al.
ANNALS OF THORACIC SURGERY (2015)
Clinical predictors of early cancer-related mortality following neoadjuvant therapy and oesophagectomy
Brendon M. Stiles et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2015)
Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma
Shinya Ohashi et al.
GASTROENTEROLOGY (2015)
Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer
Y. Hamai et al.
DISEASES OF THE ESOPHAGUS (2015)
Global incidence of oesophageal cancer by histological subtype in 2012
Melina Arnold et al.
GUT (2015)
Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy
J. Wen et al.
ANNALS OF ONCOLOGY (2014)
Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer
J. -B. Clavier et al.
DISEASES OF THE ESOPHAGUS (2014)
Hemoglobin Level Influences Tumor Response and Survival After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Yoichi Hamai et al.
WORLD JOURNAL OF SURGERY (2014)
Trimodality Therapy for Stage II-III Carcinoma of the Esophagus: A Dose-Ranging Study of Concurrent Capecitabine, Docetaxel, and Thoracic Radiotherapy
Matthew D. Wood et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Nomogram to Predict Treatment Outcome of Fluoropyrimidine/Platinum-Based Chemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
Hyun Ae Jung et al.
CANCER RESEARCH AND TREATMENT (2013)
Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
Manabu Emi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
The Number of Pathologic Lymph Nodes Involved is Still a Significant Prognostic Factor Even After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Yasunori Akutsu et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Comparative Genomic Analysis of Esophageal Adenocarcinoma and Squamous Cell Carcinoma
Nishant Agrawal et al.
CANCER DISCOVERY (2012)
Outcomes After Trimodality Therapy for Esophageal Cancer The Impact of Histology on Failure Patterns
Matthew Koshy et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Katrin M. Sjoquist et al.
LANCET ONCOLOGY (2011)
Pre- and post-therapy nodal status equally affects survival of patients with oesophageal squamous cell carcinoma receiving preoperative chemoradiation
Hiroshi Miyata et al.
ONCOLOGY REPORTS (2010)
Treatment of locally advanced esophageal cancer with surgery and chemoradiation
Peter D. Siersema et al.
CURRENT OPINION IN GASTROENTEROLOGY (2008)
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
Joel Tepper et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
AC Berger et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
